Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Inc. Alphabet currently holds 3,262,440 shares of Prime Medicine, Inc. (PRME), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Inc. Alphabet has been a net seller of PRME stock. They have purchased $12.9M and sold $180.0M worth of shares.
Inc. Alphabet's most recent insider trade was on Aug 1, 2025, when they purchased 1,500,000 shares at $3.30 per share.
Inc. Alphabet serves as Executive at Prime Medicine, Inc. (PRME). They have executed 75 insider transactions totaling $192.9M over their tenure at the company.
Inc. Alphabet holds the position of Executive at Prime Medicine, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Inc. Alphabet has shown a selling trading pattern, with $12.9M in total purchases and $180.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Inc. Alphabet was on Aug 17, 2023, when they sold $46.2M worth of OSCR shares. This transaction involved 5,719,438 shares at $8.08 per share.
Inc. Alphabet currently owns 3,262,440 shares of Prime Medicine, Inc. (PRME), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Inc. Alphabet's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Inc. Alphabet has 75 Form 4 filings on record as an insider at Prime Medicine, Inc..
Set alerts for Inc. Alphabet and 40,000+ other insiders.